Core Viewpoint - The company plans to acquire significant stakes in multiple health management subsidiaries through a share issuance, which is expected to enhance its asset scale and profitability without diluting immediate returns per share [1][3]. Group 1: Transaction Details - The company intends to purchase 84% of Hengyang Meinian Health Checkup Center, 81% of Ningde Meinian Health Management, and several other stakes in various health management companies, totaling multiple acquisitions [1]. - The transaction is structured to ensure that the company's earnings per share (EPS) will not be diluted post-transaction, with projected increases in net profit attributable to the parent company [2][3]. Group 2: Measures to Mitigate Dilution Risks - The company plans to accelerate the integration of the acquired companies to enhance profitability and operational efficiency [3]. - A commitment to improve corporate governance and operational efficiency has been established, ensuring a robust management structure and clear responsibilities among various governance bodies [4]. - The company will refine its profit distribution policy to ensure fair returns to all shareholders while maintaining sustainable growth [6]. Group 3: Commitments from Stakeholders - The actual controller and senior management have issued commitments to uphold measures that protect immediate returns, ensuring no undue interference in company operations [6]. - Specific commitments include linking compensation plans to the execution of measures aimed at mitigating dilution of immediate returns [6].

Core Viewpoint - The company intends to acquire significant equity stakes in various health management and inspection centers through a share issuance, which complies with the relevant regulations of the Major Asset Restructuring Management Measures for Listed Companies [1][2][3] Group 1: Transaction Details - The company plans to purchase 84% of Hengyang Meinian Health Examination Center Co., Ltd., 81% of Ningde Meinian Health Management Co., Ltd., 75% of Yantai Meinian Health Management Co., Ltd., and several other stakes in various health management companies [1] - The transaction includes minority stakes in several subsidiaries, such as 47.37% in Zhengzhou Meijian Health Management Co., Ltd. and 49% in Guangzhou Huadu District Meinian Health Management Co., Ltd. [1] Group 2: Compliance with Regulations - The board has conducted a thorough analysis confirming that the transaction meets the conditions outlined in Article 11, Article 43, and Article 44 of the Major Asset Restructuring Management Measures [2] - The transaction does not involve any arrangements for phased issuance of shares for asset purchase, ensuring compliance with regulatory requirements [2][3] - The board believes that the transaction will not lead to significant adverse effects on competition or independence, and it can be completed within the agreed timeframe [2][3]

Core Points - The company intends to acquire significant equity stakes in multiple health management and inspection centers through a share issuance [1][2] - The board believes that the company does not fall under any prohibitive conditions outlined in the newly implemented "Regulations on the Registration Management of Securities Issuance by Listed Companies" [2] Group 1 - The company plans to purchase 84% of Hunan Meinian Health Examination Center, 81% of Ningde Meinian Health Management, 75% of Yantai Meinian Health Management, and several other stakes in various health management companies [1] - The board has conducted a thorough analysis and concluded that there are no disqualifying conditions for the share issuance, such as negative audit opinions or administrative penalties [2] - The board's assessment confirms compliance with the relevant regulations, ensuring the legitimacy of the upcoming transaction [2]

Core Viewpoint - The company plans to acquire significant equity stakes in multiple health management and inspection centers through a share issuance transaction [1][2]. Group 1: Transaction Details - The company intends to purchase 84.00% of Hengyang Meinian Health Examination Center Co., Ltd., 81.00% of Ningde Meinian Health Management Co., Ltd., 75.00% of Yantai Meinian Health Management Co., Ltd., and other varying stakes in several subsidiaries [1]. - The transaction includes acquiring minority stakes in several companies, such as 47.37% in Zhengzhou Meijian Health Management Co., Ltd. and 42.46% in Anhui Meixin Health Management Consulting Co., Ltd. [1]. Group 2: Advisory and Legal Support - The company has engaged several third-party institutions for this transaction, including: - Yuekai Securities Co., Ltd. as the independent financial advisor - Beijing Junzejun Law Offices as the legal advisor - Zhongshun Zhonghuan Accounting Firm as the auditing agency - Jinzhen (Shanghai) Asset Appraisal Co., Ltd. as the evaluation agency [2]. - The company confirms that there are no other direct or indirect third-party institutions or individuals hired for compensation in this transaction [2].

美年大健康产业控股股份有限公司 董事会关于本次交易信息公布前 20 个交易日 公司股票价格波动情况的说明 美年大健康产业控股股份有限公司（以下简称"公司"）拟通过发行股份的方 式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德美年 大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00%股 权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管理 有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年健 康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公司 大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理有限 公司 48.05%少数股权（以下简称"本次交易"）。 综上，在剔除大盘因素和同行业板块因素影响后，公司股价在本次重大事项 披露前 20 个交易日内累计涨跌幅未超过 20%，不存在异常波动的情况。 特此说 ...

美年大健康产业控股股份有限公司 董 事 会 二〇二五年七月十一日 根据《上市规则》，上市公司董事会审议本次交易相关议案时，关联董事已 回避表决；上市公司后续在召开董事会、股东大会审议相关议案时，关联董事、 关联股东将回避表决。 特此说明。 美年大健康产业控股股份有限公司 董事会关于本次交易构成关联交易的说明 美年大健康产业控股股份有限公司（以下简称"上市公司"）拟通过发行股份 的方式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德 美年大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00% 股权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管 理有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年 健康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公司 大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理 ...

Core Viewpoint - The company intends to acquire significant equity stakes in multiple health management and medical examination companies through a share issuance, with a focus on ensuring the independence and fairness of the asset evaluation process [1][2][3] Group 1: Transaction Overview - The company plans to purchase 84% of Hunan Meinian Health Examination Center, 81% of Ningde Meinian Health Management, 75% of Yantai Meinian Health Management, and several other stakes in various health management companies [1] - The total stakes being acquired include significant minority interests in several companies, indicating a broad expansion strategy in the health management sector [1] Group 2: Evaluation Process - The company has engaged Jinzheng (Shanghai) Asset Appraisal Co., Ltd. as the asset evaluation agency, which is compliant with the Securities Law and has the necessary qualifications and experience [2] - The evaluation is based on a reference date of March 31, 2025, and aims to assess the total equity value of the target companies [2] Group 3: Evaluation Independence and Assumptions - The evaluation agency is independent, with no existing relationships or conflicts of interest with the company or the transaction parties, ensuring an unbiased assessment [2] - The assumptions set by the evaluation agency are reasonable and comply with national laws and market practices, reflecting the actual conditions of the assets [2] Group 4: Evaluation Methods and Fairness - The evaluation utilized both the income approach and asset-based approach, ultimately relying on the income approach for the final valuation of the equity [3] - The evaluation process adhered to principles of independence, objectivity, and fairness, resulting in a valuation that accurately reflects the market value of the assets as of the evaluation date [3] - The transaction pricing is based on the evaluation results, ensuring fairness and reasonableness, protecting the interests of the company and its minority shareholders [3]

Core Viewpoint - The independent directors of Meinian Onehealth Healthcare Holdings Co., Ltd. have approved a series of proposals regarding the acquisition of equity stakes in multiple companies through a share issuance, which is expected to enhance the company's business structure and profitability [1][2][3]. Group 1: Approval of Proposals - The independent directors have reviewed and approved the proposal for the company to issue shares for asset acquisition, confirming compliance with relevant laws and regulations [1]. - The transaction plan for issuing shares to purchase assets and related party transactions has been deemed reasonable and operable, benefiting the company's business structure and shareholder interests [2]. - The independent directors have also approved the draft report related to the share issuance for asset acquisition, affirming its compliance with legal requirements [2]. Group 2: Transaction Characteristics - The transaction involves acquiring stakes in 11 companies, including Hengyang Meinian Health Checkup Center Co., Ltd., and minority stakes in 5 subsidiaries, including Zhengzhou Meijian Health Management Co., Ltd. [1]. - The transaction is classified as a related party transaction due to the involvement of a company controlled by the actual controller of Meinian [3]. - It has been confirmed that the transaction does not constitute a major asset restructuring as the assets involved do not exceed 50% of the company's relevant financial metrics [4]. Group 3: Compliance and Procedures - The independent directors have confirmed that the transaction adheres to the regulatory requirements for major asset restructuring and does not involve any recent changes in control [4][5]. - The company has fulfilled all necessary legal procedures and submitted valid legal documents for the transaction [7]. - The evaluation agency selected for the transaction has been deemed independent, and the valuation methods used are considered reasonable and fair [7][9]. Group 4: Financial Aspects - The total transaction price for the equity stakes is approximately 427.78 million yuan [9]. - The company has conducted an analysis of the impact of the transaction on immediate returns and has proposed measures to mitigate any potential dilution of returns [8]. Group 5: Authorization and Future Steps - The board of directors has requested authorization from the shareholders' meeting to handle all matters related to the transaction, including adjustments to the transaction plan and execution of necessary agreements [10].

Core Viewpoint - The adjustment of the transaction plan by Meinian Health does not constitute a significant change to the restructuring plan, as confirmed by the independent financial advisor, Guangdong Kai Securities [2][8]. Group 1: Transaction Details - Meinian Health plans to acquire stakes in several health management companies, including 84.00% of Hengyang Meinian, 81.00% of Ningde Meinian, and 75.00% of Yantai Meinian, among others [1][2]. - The transaction involves a total of 14 companies, with varying ownership percentages, including minority stakes in some [1][2]. Group 2: Adjustments to the Transaction Plan - The transaction plan has been adjusted to exclude certain parties and assets, specifically reducing the number of transaction counterparties and the stakes in specific companies [3][4]. - The adjustments include the removal of Chen Xiaoping, Lin Shuping, and Liu Guanghua as transaction counterparties, and the exclusion of stakes in Xiamen Yincheng Meinian, Anxi Meinian, and Nanning Meiyuan Kang [4][8]. Group 3: Compliance with Regulations - The adjustments made to the transaction plan do not exceed the 20% threshold for significant changes as defined by the relevant regulations, thus not requiring a new shareholder meeting for approval [4][8]. - The independent financial advisor has verified that the changes comply with the regulations set forth in the Major Asset Restructuring Management Measures [4][8].

Core Viewpoint - Meinian Health Industry Holdings Co., Ltd. plans to acquire significant stakes in multiple health management and medical examination companies through a share issuance, indicating a strategic expansion in the health sector [1][2]. Group 1: Transaction Details - The transaction involves the acquisition of 84% of Hengyang Meinian Health Examination Center Co., Ltd., 81% of Ningde Meinian Health Management Co., Ltd., 75% of Yantai Meinian Health Examination Management Co., Ltd., and several other companies with varying ownership percentages [1]. - The stakes being acquired include both majority and minority interests in various health management firms across different regions, showcasing a broad geographic expansion strategy [1]. Group 2: Regulatory Compliance - Guangdong Securities Co., Ltd. conducted an independent review and confirmed that the involved parties do not face any regulatory issues related to insider trading or administrative penalties in the last 36 months, ensuring compliance with relevant regulations [2]. - The review concluded that the transaction does not violate any provisions outlined in the "Guidelines for Major Asset Restructuring of Listed Companies" and "Self-Regulatory Guidelines for Listed Companies" [2].